FDA

Celltex unsure if FDA agrees product isn’t a drug, but expects 2nd FDA visit soon

Celltex-300x241

I recently asked Celltex if they had definitely convinced the FDA their product was not a drug (i.e. the FDA confirmed their product was not a drug) or rather they had tried and hoped they had. It appears the latter is correct from the Celltex response below: Dear Dr. Knoepfler, Thank you for your interest […]

Celltex unsure if FDA agrees product isn’t a drug, but expects 2nd FDA visit soon Read More »

WSJ editorial on issue of stem cells as drugs misses the boat

Dr.-Scott-Gottlieb

Today there is an editorial piece in the WSJ about the recent court ruling giving the FDA authority to regulate stem cells grown in culture as drugs. As a stem cell scientist, I read this opinion piece with interest. Unfortunately it is behind a paywall, but I have outlined and discussed the key issues below.

WSJ editorial on issue of stem cells as drugs misses the boat Read More »

Court empowers FDA to regulate stem cells as drugs

stem-cell-drug-202x3001

Are stem cells drugs? At least for today, a federal court unambiguously ruled that the answer to this question for manipulated stem cells is “Yes”.  The story has been reported in the media at New Scientist and Scope Blog. You can read over the key issues here. The court ruled in favor of the federal government and FDA and against

Court empowers FDA to regulate stem cells as drugs Read More »

The dangerous myth of email privacy: a lesson from scientists who were spied on by the FDA

FDA

A major scandal has erupted further regarding FDA monitoring of its scientists’ emails as reported by the NY Times. The FDA spied on the emails of its own scientists and other scientists. Some of the emails also involved correspondence with Congress and even the White House. Regardless of one’s position on what the FDA did,

The dangerous myth of email privacy: a lesson from scientists who were spied on by the FDA Read More »

What’s next for Celltex? Texas adult stem cell provider that treated Rick Perry has uncertain future

Celltex is that adult stem cell company that treated Governor Perry and upwards of 80 other people with stem cell products that they grew in their lab in Texas. I wonder what the leadership of Celltex is thinking right now about its FDA audit, their future, and that pesky professor/blogger in California…what’s his name? I

What’s next for Celltex? Texas adult stem cell provider that treated Rick Perry has uncertain future Read More »

Surprising FDA audit report of Celltex a blow to dubious stem cell clinics

Celltex-300x241

As I first reported, the FDA conducted a two-week audit of Texas adult stem cell firm, Celltex, sometime in April. Today I received a copy of the so-called “483 report” of that audit. It is basically a summary of problematic issues that the FDA says need to addressed. The FDA report is cause for some

Surprising FDA audit report of Celltex a blow to dubious stem cell clinics Read More »

Dr Lookgood, dermatologist to the stars, gets FDA warning letter

Dr-LookGood1

If you ever had a really bad day, March 13, 2012 might have been just such a bad day for one Dr. Steven Victor, aka “Dr LookGood”, because he received an official warning letter from the FDA. Why? Dr. Victor, who reportedly greets each patient with the catch phrase “You look so much more beautiful than your picture”, is

Dr Lookgood, dermatologist to the stars, gets FDA warning letter Read More »

Shocker: FDA views treatment with ethylene oxide, a highly toxic carcinogen, & irradiation as minimal manipulation

What does the FDA define as “minimally manipulated” when it comes to biologics such as stem cells? You will be shocked to find out, but they include irradiation and treatment with the super toxin/carcinogen, ethylene oxide. In a recent post I discussed the issue of an apparent “minimal manipulation” exception (some might even call it a

Shocker: FDA views treatment with ethylene oxide, a highly toxic carcinogen, & irradiation as minimal manipulation Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.